Literature DB >> 8598206

An antagonist-insensitive P2X receptor expressed in epithelia and brain.

G Buell1, C Lewis, G Collo, R A North, A Surprenant.   

Abstract

A cDNA was cloned which encodes a new ATP-gated ion channel (P2X4 receptor). ATP induces a cationic current in HEK293 cells transfected with the P2X4 receptor. However, the current is almost completely insensitive to antagonists effective at other P2X receptors. Sensitivity to two of these antagonists (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid and pyridoxal 5-phosphate) is restored by replacement of Glu249 by lysine, which occurs at the equivalent position in P2X1 and P2X2 receptors. P2X4 RNA is found by in situ hybridization in the brain, peripheral ganglia and epithelia including serosal cells of salivary glands. Recordings from rat submandibular gland cells showed ATP-induced currents that are also insensitive to antagonists. These results define a further member of P2X receptor family, and they identify an amino acid residue involved in antagonist binding. They also introduce a new phenotype for ATP responses at P2X receptors--insensitivity to currently known antagonists.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598206      PMCID: PMC449917     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  ATP-gated current in dissociated rat nucleus solitarii neurons.

Authors:  S Ueno; N Harata; K Inoue; N Akaike
Journal:  J Neurophysiol       Date:  1992-09       Impact factor: 2.714

2.  Extracellular ATP activates receptor-operated cation channels in mouse lacrimal acinar cells to promote calcium influx in the absence of phosphoinositide metabolism.

Authors:  T Sasaki; D V Gallacher
Journal:  FEBS Lett       Date:  1990-05-07       Impact factor: 4.124

3.  Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens.

Authors:  P M Dunn; A G Blakeley
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP.

Authors:  R J Evans; A Surprenant
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

5.  ATP mediates fast synaptic transmission in mammalian neurons.

Authors:  R J Evans; V Derkach; A Surprenant
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

6.  The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder.

Authors:  L Kasakov; G Burnstock
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

7.  A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine.

Authors:  E M Fenwick; A Marty; E Neher
Journal:  J Physiol       Date:  1982-10       Impact factor: 5.182

8.  ATP receptor-mediated synaptic currents in the central nervous system.

Authors:  F A Edwards; A J Gibb; D Colquhoun
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

9.  Cationic channels sensitive to extracellular ATP in rat lacrimal cells.

Authors:  P Vincent
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

10.  Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.

Authors:  P Sneddon; D P Westfall
Journal:  J Physiol       Date:  1984-02       Impact factor: 5.182

View more
  111 in total

1.  Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission.

Authors:  G D Housley; R Kanjhan; N P Raybould; D Greenwood; S G Salih; L Järlebark; L D Burton; V C Setz; M B Cannell; C Soeller; D L Christie; S Usami; A Matsubara; H Yoshie; A F Ryan; P R Thorne
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells.

Authors:  R Janssens; J M Boeynaems
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

5.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

6.  Single channel properties of P2X2 purinoceptors.

Authors:  S Ding; F Sachs
Journal:  J Gen Physiol       Date:  1999-05       Impact factor: 4.086

7.  P2X receptor expression in mouse urinary bladder and the requirement of P2X(1) receptors for functional P2X receptor responses in the mouse urinary bladder smooth muscle.

Authors:  C Vial; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 8.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

9.  Expression and function of P2X purinoceptors in rat histaminergic neurons.

Authors:  Vladimir S Vorobjev; Irina N Sharonova; Helmut L Haas; Olga A Sergeeva
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

10.  P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.

Authors:  Jonathan W Bowler; R Jayne Bailey; R Alan North; Annmarie Surprenant
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.